Journal article
Establishing subclasses of childhood eczema, their risk factors and prognosis
DJ Lopez, CJ Lodge, DS Bui, NT Waidyatillake, MJ Abramson, JL Perret, JC Su, B Erbas, C Svanes, SC Dharmage, AJ Lowe
Clinical and Experimental Allergy | WILEY | Published : 2022
DOI: 10.1111/cea.14139
Abstract
Background: The heterogeneity of development and progression of eczema suggests multiple underlying subclasses for which aetiology and prognosis may vary. A better understanding may provide a comprehensive overview of eczema development and progression in childhood. Thus, we aimed to determine longitudinal eczema subclasses based on assessments and identify their associations with risk factors and allergic outcomes. Methods: A total of 619 participants with a family history of allergic disease were assessed at 24 time-points from birth to 12 years. At each time, eczema was defined as the report of current rash treated with topical steroid-based preparations. Longitudinal latent class analysi..
View full abstractRelated Projects (2)
Grants
Awarded by Nestec
Funding Acknowledgements
The first 12 years of the MACS was funded (study formula and staff) by Nestec Ltd, a subsidiary of Nestle Australia. The National Health and Medical Research Council of Australia funded the 18-(GNT454856) and 25-year (GNT1079668) follow-ups. All bodies that have funded aspects of the MACS have had no role in interpretation and publication of study findings